T. Rowe Price Associates
KRRO icon

T. Rowe Price Associates’s Korro Bio KRRO Stock Holding History

T. Rowe Price Associates’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-479
Closed -$169K – 3017
2021
Q3 		$169K Buy
479
+26
+6% +$10.2K ﹤0.01% 2760
2021
Q2 		$225K Buy
453
+156
+53% +$76.2K ﹤0.01% 2686
2021
Q1 		$141K Buy
297
+135
+83% +$262K ﹤0.01% 2752
2020
Q4 		$285K Buy
+162
New +$214K ﹤0.01% 2437

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates's KRRO Position: Q4 2021 in Review

T. Rowe Price Associates sold out of Korro Bio (KRRO) in Q4 2021, closing a stake of 479 shares — an estimated $169K sold.

T. Rowe Price Associates first reported a position in KRRO in Q4 2020 and held it in 4 quarters. The position peaked at $285K in Q4 2020. 82 funds tracked by Wall St. Rank hold KRRO as of Q4 2021.

  • T. Rowe Price Associates reported no remaining Korro Bio position as of Q4 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 479 Korro Bio shares in Q4 2021, an estimated $169K.
  • T. Rowe Price Associates first reported a position in Korro Bio in Q4 2020 and held it in 4 quarters.
  • T. Rowe Price Associates's Korro Bio position peaked at $285K in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Korro Bio as of Q4 2021.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.